OrSense Ltd.
OrSense makes non-invasive medical monitoring equipment, based on a technology called Occlusion Spectroscopy, that measures levels of blood glucose and hemoglobin via a ring-shaped cuff, which generates a readable transmission signal when placed on the finger. Patients can self-test with OrSense's devices, which are useful for anemia screening and diabetes monitoring. Biophysicist and company CTO Ilya Fine founded OrSense in 1996 after inventing its core technology. Leading investors include STAR Ventures and Israel Health Care Ventures.
Contact Details
Executives
CEO
Lior D. Ma'ayan
VP Operations
Ephraim Gabis